Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-12-031210
Filing Date
2012-06-26
Accepted
2012-06-26 16:16:57
Documents
1
Period of Report
2012-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6536
  Complete submission text file 0001140361-12-031210.txt   7980
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 202-306 LINE APT BONGSEON-DONG, NAM-GU GWANGJU M4 503
Business Address
Hwang Si Moon (Reporting) CIK: 0001552942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 12927415